President and CEO, deCODE Genetics, Reykjavik, Iceland
Kári Stefánsson has served as President,
Chief Executive Officer and Director since he co-founded
deCODE in August 1996. Dr. Stefánsson was
appointed to serve as the Chairman of the company's
Board of Directors in December 1999. From 1993 until
April 1997, Dr. Stefansson was a professor of Neurology,
Neuropathology and Neuroscience at Harvard University.
In addition, from 1993 through December 1996 he
was Director of Neuropathology at Beth Israel Hospital
in Boston, Massachusetts. From 1983 to 1993, he
held faculty positions in Neurology, Neuropathology
and Neurosciences at the University of Chicago.
Dr. Stefansson received his M.D. and Dr.Med. from
the University of Iceland. |
